Grozdanov Lubomir, Raasch Carsten, Schulze Jürgen, Sonnenborn Ulrich, Gottschalk Gerhard, Hacker Jörg, Dobrindt Ulrich
Institut für Molekulare Infektionsbiologie, Universität Würzburg, Wuerzburg, Germany.
J Bacteriol. 2004 Aug;186(16):5432-41. doi: 10.1128/JB.186.16.5432-5441.2004.
Nonpathogenic Escherichia coli strain Nissle 1917 (O6:K5:H1) is used as a probiotic agent in medicine, mainly for the treatment of various gastroenterological diseases. To gain insight on the genetic level into its properties of colonization and commensalism, this strain's genome structure has been analyzed by three approaches: (i) sequence context screening of tRNA genes as a potential indication of chromosomal integration of horizontally acquired DNA, (ii) sequence analysis of 280 kb of genomic islands (GEIs) coding for important fitness factors, and (iii) comparison of Nissle 1917 genome content with that of other E. coli strains by DNA-DNA hybridization. PCR-based screening of 324 nonpathogenic and pathogenic E. coli isolates of different origins revealed that some chromosomal regions are frequently detectable in nonpathogenic E. coli and also among extraintestinal and intestinal pathogenic strains. Many known fitness factor determinants of strain Nissle 1917 are localized on four GEIs which have been partially sequenced and analyzed. Comparison of these data with the available knowledge of the genome structure of E. coli K-12 strain MG1655 and of uropathogenic E. coli O6 strains CFT073 and 536 revealed structural similarities on the genomic level, especially between the E. coli O6 strains. The lack of defined virulence factors (i.e., alpha-hemolysin, P-fimbrial adhesins, and the semirough lipopolysaccharide phenotype) combined with the expression of fitness factors such as microcins, different iron uptake systems, adhesins, and proteases, which may support its survival and successful colonization of the human gut, most likely contributes to the probiotic character of E. coli strain Nissle 1917.
非致病性大肠杆菌菌株Nissle 1917(O6:K5:H1)在医学上用作益生菌剂,主要用于治疗各种胃肠疾病。为了从基因水平深入了解其定植和共生特性,已通过三种方法分析了该菌株的基因组结构:(i)tRNA基因的序列上下文筛选,作为水平获得的DNA染色体整合的潜在指标;(ii)对编码重要适应性因子的280 kb基因组岛(GEIs)进行序列分析;(iii)通过DNA-DNA杂交比较Nissle 1917基因组内容与其他大肠杆菌菌株的基因组内容。基于PCR对324株不同来源的非致病性和致病性大肠杆菌分离株进行筛选,结果显示一些染色体区域在非致病性大肠杆菌以及肠外和肠道致病菌株中经常可检测到。Nissle 1917菌株的许多已知适应性因子决定簇位于四个已部分测序和分析的GEIs上。将这些数据与大肠杆菌K-12菌株MG1655以及尿路致病性大肠杆菌O6菌株CFT073和536的基因组结构现有知识进行比较,发现在基因组水平上存在结构相似性,特别是在大肠杆菌O6菌株之间。缺乏明确的毒力因子(即α-溶血素、P菌毛黏附素和半粗糙脂多糖表型),同时表达如微菌素、不同的铁摄取系统、黏附素和蛋白酶等适应性因子,这些因子可能支持其在人类肠道中的存活和成功定植,很可能有助于大肠杆菌菌株Nissle 1917的益生菌特性。